$8.54
0.40[4.91%]
Last update: 3:05PM Get Real Time Here
Acrivon Therapeutics
(NASDAQ:ACRV)Acrivon Therapeutics Stock (NASDAQ:ACRV), Quotes and News Summary
Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
| Open | $8.140 |
| Close | - |
| Volume / Avg. | 60.988K / 782.353K |
| Day Range | 7.980 - 8.640 |
| 52 Wk Range | 3.190 - 14.300 |
| Market Cap | $263.676M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 8.77% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acrivon Therapeutics (ACRV) stock?
You can purchase shares of Acrivon Therapeutics (NASDAQ: ACRV) through any online brokerage.
Who are Acrivon Therapeutics's (ACRV) competitors?
Other companies in Acrivon Therapeutics’s space includes: Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).
What is the target price for Acrivon Therapeutics (ACRV) stock?
The latest price target for Acrivon Therapeutics (NASDAQ: ACRV) was reported by Ladenburg Thalmann on Monday, April 29, 2024. The analyst firm set a price target for 0.00 expecting ACRV to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Acrivon Therapeutics (ACRV)?
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $8.14 last updated May 9, 2024 at 4:00 PM EDT.
Does Acrivon Therapeutics (ACRV) pay a dividend?
There are no upcoming dividends for Acrivon Therapeutics.
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Acrivon Therapeutics (ACRV) going to split?
There is no upcoming split for Acrivon Therapeutics.
What sector and industry does Acrivon Therapeutics (ACRV) operate in?
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.